Quinazolinones as Inhibitors of Human Phosphatidylinositol 3-Kinase Delta
US 7,932,260 Surrendered on reissueSurrendered on reissue Dec 10, 2013 · Medium confidence
20-year base term ended May 12, 2025
Why Medium: No fee event states this; the fee state is read from the payments the fee record holds.
Surrendered on reissue Dec 10, 2013 · its term and maintenance fees continue in US RE44,638.
May 12, 2005
Dec 10, 2013
Apr 26, 2011
Aug 5, 2025
How we calculated this date
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts May 12, 2005, when the earliest non-provisional application in its chain was filed (this one was filed Dec 14, 2007) | May 12, 2025 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +85 days, USPTO patent term adjustment record | Aug 5, 2025 | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | No fee events in USPTO's record of this patent. A gap in the record, not evidence of lapse | no change | Medium confidence |
| Reissue | US RE44,638 issued Dec 10, 2013, and this patent's term continues in it (35 U.S.C. 251, 252) | surrendered Dec 10, 2013 | High confidence |
| Surrendered on reissue | The steps above, in order | Dec 10, 2013 | Medium confidence |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Not on this page: the patent's family, its recorded assignments and its citation count. USPTO's assignment records, linked above, list every recorded assignment.
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.